feed,title,long_url,short_url
SeekingAlpha,Avrobio up 69% on plans to sell gene therapy program to Novartis,https://seekingalpha.com/news/3973729,
SeekingAlpha,Hepion Pharma NASH candidate meets phase 2 goal; up 68%,https://seekingalpha.com/news/3973725,
SeekingAlpha,JPMorgan raises year NII outlook due to First Republic deal,https://seekingalpha.com/news/3973728,
